Skip to main content
. 2006 Jul;8(3):320–329. doi: 10.2353/jmoldx.2006.050136

Table 3.

Gene Marker Candidates Tested and Testing Summary

Tissue type Name Identification method
Marker selection filters
Gene expression database query Literature Low expression in corresponding metastatic tissue Marker redundancy Tissue cross-reactivity Marker adequate?
Lung SP-B x x x
TTF1 x x x
DSG3 x x
Pancreas PSCA x x
F5 x x
ITGB6 x x
TGM2 x x
MUC4 x x x
SERPINA 1 x x
KRT7 x x x
MMP11 x x
Colon HPT1 x x x
FABP1 x x
CDX1 x x x
GUCY2C x x x
Prostate PSA x x x
hKLK2 x x x
Breast MGB1 x x x
PIP x x x
PDEF x x
Ovarian HE4 x x x
PAX8 x x x
WT1 x x x

KRT7, cytokeratin 7; MMP11, matrix metalloprotease 11; MUC4, mucin 4; PDEF, prostate-derived Ets transcription factor; SERPINA 1, serine proteinase inhibitor, clade A member 1.